ArticleEnvironmental monitoring and assessment2026
Application of volumetric absorptive microsampling (VAMS) for the simultaneous determination of cadmium and lead in blood.
Article in Environmental monitoring and assessment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cadmium (Cd) and lead (Pb) are toxic elements. This study evaluates the applicability of volumetric absorptive microsampling (VAMS) as an alternative sampling method for biomonitoring of Cd and Pb in human blood. VAMS and blood samples were collected from 60 participants using untreated VAMS. Furthermore, samples from additional 27 participants were collected using VAMS pre-cleaned with 0.5% (v/v) nitric acid to reduce background levels in VAMS and improve performance. All samples were extracted (VAMS) or diluted (venous blood) with 0.5% (v/v) nitric acid prior to analysis by ICP-MS. For untreated VAMS, geometric mean (GM) recovery was 106.2% for Cd and 102.8% for Pb. For pre-cleaned VAMS, GM recovery was 117.2% for Cd and 104.6% for Pb. A strong correlation (Spearman Rho) between both methods was found (Cd, ρ = 0.84; Pb, ρ = 0.93). Correlation improved (Cd, ρ = 0.91; Pb, ρ = 0.98) for pre-cleaned VAMS. For untreated VAMS, the limits of quantification (LOQ) were 0.42 µg/l for Cd and 15.3 µg/l Pb. Pre-cleaning of VAMS led to a 90% background reduction for Pb (0.35 µg/l vs 3.61 µg/l). Background of Cd was unaffected by pre-cleaning (0.05 µg/l vs 0.07 µg/l). LOQs for pre-cleaned VAMS were 0.45 µg/l for Cd and 2.10 µg/l for Pb. Despite challenges like the background, VAMS is a promising alternative sampling method for human biomonitoring of Cd and Pb in blood. This study demonstrates the benefits of washing VAMS to reduce background.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.